PURPOSE OF REVIEW: Left ventricular assist devices (LVADs) have markedly improved the survival for patients with advanced heart failure but are plagued with significant morbidity, including pump thrombosis and bleeding. Better understanding of the platelet, and its role in the balance of bleeding and thrombosis, stands to impact the frequency and treatment of these significant complications. RECENT FINDINGS: In patients with LVADs, there is little consistency linking traditional biomarkers of platelet activation and clinical events. A number of innovative methods of assessing platelet functionality, including shedding of platelet receptors and formation of microparticle complexes as well as measuring mitochondrial membrane potentials, exist and appear to be clinically relevant. Acquired von Willebrand syndrome, while not explaining all bleeding events, is a central feature of mechanical support and offers a target for innovative therapies. SUMMARY: Although the platelet is only one component of impacting thrombosis and bleeding in patients supported with LVADs, it plays a central role in mediating these two opposing forces. Innovations in understanding platelet physiology as well as manipulating genomic and receptor interactions for an individual patient will be critical if we are to decrease these serious adverse events in the future.
PURPOSE OF REVIEW: Left ventricular assist devices (LVADs) have markedly improved the survival for patients with advanced heart failure but are plagued with significant morbidity, including pump thrombosis and bleeding. Better understanding of the platelet, and its role in the balance of bleeding and thrombosis, stands to impact the frequency and treatment of these significant complications. RECENT FINDINGS: In patients with LVADs, there is little consistency linking traditional biomarkers of platelet activation and clinical events. A number of innovative methods of assessing platelet functionality, including shedding of platelet receptors and formation of microparticle complexes as well as measuring mitochondrial membrane potentials, exist and appear to be clinically relevant. Acquired von Willebrand syndrome, while not explaining all bleeding events, is a central feature of mechanical support and offers a target for innovative therapies. SUMMARY: Although the platelet is only one component of impacting thrombosis and bleeding in patients supported with LVADs, it plays a central role in mediating these two opposing forces. Innovations in understanding platelet physiology as well as manipulating genomic and receptor interactions for an individual patient will be critical if we are to decrease these serious adverse events in the future.
Authors: Keith D Aaronson; Mark S Slaughter; Leslie W Miller; Edwin C McGee; William G Cotts; Michael A Acker; Mariell L Jessup; Igor D Gregoric; Pranav Loyalka; O H Frazier; Valluvan Jeevanandam; Allen S Anderson; Robert L Kormos; Jeffrey J Teuteberg; Wayne C Levy; David C Naftel; Richard M Bittman; Francis D Pagani; David R Hathaway; Steven W Boyce Journal: Circulation Date: 2012-05-22 Impact factor: 29.690
Authors: Mark S Slaughter; Michael A Sobieski; Joel D Graham; Patroklos S Pappas; Antone J Tatooles; Steven C Koenig Journal: Int J Artif Organs Date: 2011-06 Impact factor: 1.595
Authors: Zengsheng Chen; Nandan K Mondal; Jun Ding; Steven C Koenig; Mark S Slaughter; Bartley P Griffith; Zhongjun J Wu Journal: Mol Cell Biochem Date: 2015-07-10 Impact factor: 3.396
Authors: Randall C Starling; Nader Moazami; Scott C Silvestry; Gregory Ewald; Joseph G Rogers; Carmelo A Milano; J Eduardo Rame; Michael A Acker; Eugene H Blackstone; John Ehrlinger; Lucy Thuita; Maria M Mountis; Edward G Soltesz; Bruce W Lytle; Nicholas G Smedira Journal: N Engl J Med Date: 2013-11-27 Impact factor: 91.245
Authors: Omar Wever-Pinzon; Craig H Selzman; Stavros G Drakos; Abdulfattah Saidi; Gregory J Stoddard; Edward M Gilbert; Mohamed Labedi; Bruce B Reid; Erin S Davis; Abdallah G Kfoury; Dean Y Li; Josef Stehlik; Feras Bader Journal: Circ Heart Fail Date: 2013-03-11 Impact factor: 8.790
Authors: Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier Journal: N Engl J Med Date: 2009-11-17 Impact factor: 91.245
Authors: Callie Frey; Antigoni G Koliopoulou; Emilie Montenont; Neal D Tolley; Hadi Javan; Stephen H McKellar; Stavros G Drakos; Craig H Selzman; Matthew T Rondina Journal: Platelets Date: 2020-01-14 Impact factor: 3.862
Authors: Marvin J Slepian; Jawaad Sheriff; Marcus Hutchinson; Phat Tran; Naing Bajaj; Joe G N Garcia; S Scott Saavedra; Danny Bluestein Journal: J Biomech Date: 2016-11-10 Impact factor: 2.712
Authors: Madina R Zhalbinova; Saule E Rakhimova; Ulan A Kozhamkulov; Gulbanu A Akilzhanova; Galina K Kaussova; Kenes R Akilzhanov; Yuriy V Pya; Joseph H Lee; Makhabbat S Bekbossynova; Ainur R Akilzhanova Journal: J Pers Med Date: 2022-05-04